Document Detail

Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients.
MedLine Citation:
PMID:  20975635     Owner:  NLM     Status:  In-Process    
OBJECTIVE: Premature atherosclerosis is well-documented both in Systemic Lupus Erythematosus (SLE) and in Rheumatoid Arthritis (RA) patients, but cardiovascular (CV) risk is particularly high in lupus women. Although conventional CV risk factors do not fully explain the excessive risk in inflammatory diseases, they remain major contributors to atherosclerosis. The aim of the present study was to investigate whether CV risk factors are differentially associated with SLE and RA.
METHODS: One hundred women with SLE, 98 with RA and 102 controls matched on age and without overt CV or renal disease were assessed for the presence of Framingham (hypertension, hypercholesterolemia, low HDL, diabetes, smoking) and other CV risks (atherogenic index of plasma (AIP), insulin resistance, obesity, central obesity, metabolic syndrome, uric acid, sedentarism, hypothyroidism and family history of premature CV disease).
RESULTS: Modifiable CV risk factors are highly prevalent and occur more frequently in SLE and RA than in age-matched controls. Some differences in Framingham risk factors were found between SLE and RA, with hypertension being more common in young lupus women, hypercholesterolemia more frequent in RA and low HDL-C more frequent in SLE. However, the estimated 10-year Framingham CHD risk or the Reynolds Risk Score was comparable in both diseases. Although hypercholesterolemia was more frequent in RA, lupus women display a more atherogenic lipid profile, with significantly lower HDL-C levels (56.5±16 mg/dl versus 63.7±18; p=0.005), and more cases above the high risk cutpoints for cholesterol/HDL-C (14% versus 4.1%; p=0.01) and for AIP (15% versus 6.1%; p=0.03). Also, uric acid levels are higher in SLE women (4.8±1.5 mg/dl) than in RA (4.1±1.1 mg/dl), p=0.001. On the other hand, insulin resistance is significantly higher in women with RA as compared with SLE (median HOMA-IR 3.5 [6.4]) versus 0.72 [2.5]; p<0.0001) and the difference remained significant after adjustment for BMI and corticosteroids.
CONCLUSIONS: Cardiovascular risk profile is distinct in SLE and RA women and the contribution of traditional CV risk factors to atherogenesis may be different in these two diseases. Prospective studies are necessary to understand how the control of modifiable risks can improve CV outcome in different inflammatory settings.
Maria José Santos; Filipe Vinagre; José José Silva; Victor Gil; João Eurico Fonseca
Related Documents :
20863485 - Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients.
14681505 - Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.
14769525 - Specific cardiomyopathy in lupus patients: report of three cases.
9741545 - Anticardiolipin and anti-beta2-glycoprotein i antibodies in behcet's disease.
16295825 - Eosinophilic enteritis with systemic lupus erythematosus.
12084445 - Voxel-based comparison of regional cerebral glucose metabolism between psp and corticob...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta reumatológica portuguesa     Volume:  35     ISSN:  0303-464X     ISO Abbreviation:  Acta Reumatol Port     Publication Date:    2010 Jul-Sep
Date Detail:
Created Date:  2010-10-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0431702     Medline TA:  Acta Reumatol Port     Country:  Portugal    
Other Details:
Languages:  eng     Pagination:  325-32     Citation Subset:  IM    
Rheumatology Research Unit, Instituto de Medicina Molecular da Faculdade de Medicina da Universidade de Lisboa, Edifício Egas Moniz, Lisbon, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  NEAR study: Needs and Expectations in Rheumatoid ARthritis - do we know our patients needs?
Next Document:  Translation into Brazilian Portuguese, cultural adaptation and validatation of the systemic lupus er...